1. Home
  2. ONCO vs GXAI Comparison

ONCO vs GXAI Comparison

Compare ONCO & GXAI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Onconetix Inc.

ONCO

Onconetix Inc.

HOLD

Current Price

$1.21

Market Cap

755.3K

Sector

Health Care

ML Signal

HOLD

Logo Gaxos.ai Inc.

GXAI

Gaxos.ai Inc.

HOLD

Current Price

$1.17

Market Cap

13.5M

Sector

N/A

ML Signal

HOLD

Company Overview

Basic Information
Metric
ONCO
GXAI
Founded
2018
2021
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
755.3K
13.5M
IPO Year
2021
2022

Fundamental Metrics

Financial Performance
Metric
ONCO
GXAI
Price
$1.21
$1.17
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
4.2M
276.1K
Earning Date
06-11-2026
05-14-2026
Dividend Yield
N/A
N/A
EPS Growth
22.80
71.35
EPS
N/A
N/A
Revenue
$815,371.00
$1,933,030.00
Revenue This Year
N/A
$271.23
Revenue Next Year
N/A
$36.32
P/E Ratio
N/A
N/A
Revenue Growth
N/A
47901.74
52 Week Low
$0.07
$1.02
52 Week High
$7.65
$2.96

Technical Indicators

Market Signals
Indicator
ONCO
GXAI
Relative Strength Index (RSI) 63.94 45.40
Support Level $0.49 $1.04
Resistance Level $1.87 $1.31
Average True Range (ATR) 0.09 0.06
MACD 0.11 -0.00
Stochastic Oscillator 82.22 46.47

Price Performance

Historical Comparison
ONCO
GXAI

About ONCO Onconetix Inc.

Onconetix Inc is a commercial-stage biotechnology company focused on the research, development, and commercialization of solutions for men's health and oncology. The company owns Proclarix, an in vitro diagnostic test for prostate cancer, approved for sale in the European Union. Additionally, it is focused on marketing Proclarix in the U.S. as a lab-developed product. Onconetix operates in one segment: commercial. Geographically, the company generates maximum revenue from Switzerland and the rest from the United Kingdom.

About GXAI Gaxos.ai Inc.

Gaxos.AI Inc is a technology company focused on reshaping the way people interact with artificial intelligence across everyday life and high-impact industries. It is engaged in building a portfolio of AI-powered solutions designed to make advanced technology more practical, accessible, and transformative. The company's portfolio spans defense, health and wellness, entertainment, and productivity - bringing intelligent tools to markets where innovation can drive meaningful real-world outcomes. It operates as a single operating segment technology-based company that is developing applications aimed at redefining the way it utilizes artificial intelligence (AI) to optimize the user experience.

Share on Social Networks: